Standardized senna in the management of constipation in the puerperium: A clinical trial
Standardized senna in the management of constipation in the puerperium: A clinical trial
Shelton et al., 1980 | S Afr Med J | Rct
Citation
Shelton M G. Standardized senna in the management of constipation in the puerperium: A clinical trial. S Afr Med J. 1980-Jan-19;57(3):78-80
Abstract
Successful treatment of constipation in the immediate postpartum period in 93% of White patients and 96% of Coloured patients was achieved in a clinical trial of standardized senna tablets (Senokot; Reckitt & Colman). This is significantly better than the success rates of 51% and 59% achieved in White and Coloured controls treated with a placebo. Minor abdominal cramps occurred in some 13% of the patients treated with standardized senna, and in 4% of the controls given the placebo. There is no evidence to suggest that standardized senna has any effect whatsoever on a breast-fed baby if taken by the mother.
Key Findings
There is no evidence to suggest that standardized senna has any effect whatsoever on a breast-fed baby if taken by the mother.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Adult
- Breast Feeding
- Clinical Trials as Topic
- Constipation
- Diarrhea, Infantile
- Double-Blind Method
- Female
- Humans
- Pregnancy
- Puerperal Disorders
- Senna Extract
Evidence Classification
- Level: Rct
- Publication Types: Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
- Vertical: senna
Provenance
- PMID: 6996138
- DOI: (not available)
- PMCID: Not in PMC
- Verified: 2026-04-12 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-12